vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and First Foundation Inc. (FFWM). Click either name above to swap in a different company.

Bioceres Crop Solutions Corp. is the larger business by last-quarter revenue ($77.6M vs $48.4M, roughly 1.6× First Foundation Inc.). Bioceres Crop Solutions Corp. runs the higher net margin — -9.6% vs -97.9%, a 88.3% gap on every dollar of revenue. On growth, First Foundation Inc. posted the faster year-over-year revenue change (421.7% vs -16.8%). Over the past eight quarters, First Foundation Inc.'s revenue compounded faster (-2.7% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

John B. Lacson Colleges Foundation (Bacolod), Inc. is a private maritime college in Bacolod, Negros Occidental, Philippines.

BIOX vs FFWM — Head-to-Head

Bigger by revenue
BIOX
BIOX
1.6× larger
BIOX
$77.6M
$48.4M
FFWM
Growing faster (revenue YoY)
FFWM
FFWM
+438.5% gap
FFWM
421.7%
-16.8%
BIOX
Higher net margin
BIOX
BIOX
88.3% more per $
BIOX
-9.6%
-97.9%
FFWM
Faster 2-yr revenue CAGR
FFWM
FFWM
Annualised
FFWM
-2.7%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BIOX
BIOX
FFWM
FFWM
Revenue
$77.6M
$48.4M
Net Profit
$-7.4M
$-8.0M
Gross Margin
46.8%
Operating Margin
9.3%
-97.5%
Net Margin
-9.6%
-97.9%
Revenue YoY
-16.8%
421.7%
Net Profit YoY
-20.2%
43.0%
EPS (diluted)
$-0.12
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
FFWM
FFWM
Q4 25
$48.4M
Q3 25
$77.6M
$63.6M
Q2 25
$51.4M
Q1 25
$60.6M
$71.4M
Q4 24
$98.8M
$9.3M
Q3 24
$93.3M
$9.2M
Q2 24
$57.5M
Q1 24
$84.0M
$51.1M
Net Profit
BIOX
BIOX
FFWM
FFWM
Q4 25
$-8.0M
Q3 25
$-7.4M
$-146.3M
Q2 25
$-7.7M
Q1 25
$-1.6M
$6.9M
Q4 24
$605.2K
$-14.1M
Q3 24
$-6.2M
$-82.2M
Q2 24
$3.1M
Q1 24
$9.8M
$793.0K
Gross Margin
BIOX
BIOX
FFWM
FFWM
Q4 25
Q3 25
46.8%
Q2 25
Q1 25
39.4%
Q4 24
42.0%
Q3 24
40.2%
Q2 24
Q1 24
50.8%
Operating Margin
BIOX
BIOX
FFWM
FFWM
Q4 25
-97.5%
Q3 25
9.3%
-92.7%
Q2 25
-21.1%
Q1 25
1.5%
8.8%
Q4 24
14.5%
-247.7%
Q3 24
2.5%
-1276.7%
Q2 24
4.6%
Q1 24
15.7%
-0.2%
Net Margin
BIOX
BIOX
FFWM
FFWM
Q4 25
-97.9%
Q3 25
-9.6%
-230.1%
Q2 25
-15.0%
Q1 25
-2.6%
9.7%
Q4 24
0.6%
-152.2%
Q3 24
-6.6%
-896.9%
Q2 24
5.4%
Q1 24
11.6%
1.6%
EPS (diluted)
BIOX
BIOX
FFWM
FFWM
Q4 25
$-0.09
Q3 25
$-0.12
$-1.78
Q2 25
$-0.09
Q1 25
$-0.02
$0.08
Q4 24
$0.00
$-0.24
Q3 24
$-0.10
$-1.23
Q2 24
$0.05
Q1 24
$0.14
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
FFWM
FFWM
Cash + ST InvestmentsLiquidity on hand
$15.5M
$1.6B
Total DebtLower is stronger
Stockholders' EquityBook value
$288.3M
$912.6M
Total Assets
$734.9M
$11.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
FFWM
FFWM
Q4 25
$1.6B
Q3 25
$15.5M
$1.7B
Q2 25
$1.1B
Q1 25
$38.5M
$1.0B
Q4 24
$29.2M
$1.0B
Q3 24
$32.3M
$1.1B
Q2 24
$1.4B
Q1 24
$16.4M
$1.6B
Stockholders' Equity
BIOX
BIOX
FFWM
FFWM
Q4 25
$912.6M
Q3 25
$288.3M
$917.9M
Q2 25
$1.1B
Q1 25
$345.0M
$1.1B
Q4 24
$346.3M
$1.1B
Q3 24
$346.0M
$1.1B
Q2 24
$933.2M
Q1 24
$348.5M
$928.7M
Total Assets
BIOX
BIOX
FFWM
FFWM
Q4 25
$11.9B
Q3 25
$734.9M
$11.9B
Q2 25
$11.6B
Q1 25
$798.2M
$12.6B
Q4 24
$835.2M
$12.6B
Q3 24
$827.3M
$13.4B
Q2 24
$13.7B
Q1 24
$836.1M
$13.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
FFWM
FFWM
Operating Cash FlowLast quarter
$14.4M
$-31.9M
Free Cash FlowOCF − Capex
$-35.2M
FCF MarginFCF / Revenue
-72.8%
Capex IntensityCapex / Revenue
6.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-45.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
FFWM
FFWM
Q4 25
$-31.9M
Q3 25
$14.4M
$9.2M
Q2 25
$-16.3M
Q1 25
$23.3M
$-552.0K
Q4 24
$-5.4M
$-8.7M
Q3 24
$5.2M
$14.2M
Q2 24
$-9.1M
Q1 24
$-17.4M
$7.2M
Free Cash Flow
BIOX
BIOX
FFWM
FFWM
Q4 25
$-35.2M
Q3 25
$8.6M
Q2 25
$-16.7M
Q1 25
$-2.5M
Q4 24
$-11.4M
Q3 24
$13.4M
Q2 24
$-9.4M
Q1 24
$5.9M
FCF Margin
BIOX
BIOX
FFWM
FFWM
Q4 25
-72.8%
Q3 25
13.5%
Q2 25
-32.4%
Q1 25
-3.5%
Q4 24
-123.5%
Q3 24
146.2%
Q2 24
-16.3%
Q1 24
11.6%
Capex Intensity
BIOX
BIOX
FFWM
FFWM
Q4 25
6.9%
Q3 25
1.0%
Q2 25
0.8%
Q1 25
2.8%
Q4 24
29.4%
Q3 24
9.0%
Q2 24
0.4%
Q1 24
2.5%
Cash Conversion
BIOX
BIOX
FFWM
FFWM
Q4 25
Q3 25
Q2 25
Q1 25
-0.08×
Q4 24
-8.85×
Q3 24
Q2 24
-2.96×
Q1 24
-1.78×
9.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons